Article type
Year
Abstract
Background:
The Cochrane International Mobility programme provides networking opportunities for people to learn from Cochrane colleagues in different parts of the world. The structure connects people and locations, facilitating exchange that enhances international collaboration and sharing best practice within Cochrane. The programme is open to anyone interested in contributing to Cochrane’s work. Cochrane Centres in Sweden, Austria, Italy, and The Netherlands began this initiative with several successful student exchanges. Online courses replaced in-person internships during Covid. The Neurological Sciences Field, following their past experience with in-person training courses in different European countries, including two residential ‘Summer Schools’ held in Umbria, Italy (2018-2019), decided to offer a one-year online course in 2020. An opportunity, given Covid restrictions, to continue training Cochrane methodology.
Objectives:
Training new Cochrane review authors, knowledgeable in Cochrane methodology, with the aim of working together to produce a Cochrane systematic review.
Methods:
The online course was published through Cochrane TaskExchange; applications from neurologists and trainees living and working in different parts of the world were received. Six professionals were accepted, two in the US, two in Italy, one in Syria, one in Colombia. The course began in November 2020 and ended in December 2021 (Image 1). Five online lessons (Fig. 1) and five workshops with expert lecturers were organized (Fig. 2). Exercises were carried out in small groups between each lesson or workshop.
Outcomes:
Publication and successive citations of the review will represent outcome measures.
Conclusions:
Choosing a topic relevant to end-users and working together with course experts and the PaPaS CRG was an enthusiastic experience for new Cochrane authors. The review title proposed is ‘Prophylactic treatment with monoclonal antibodies targeting the CGRP pathway for migraine prevention.’
The protocol has been submitted following Cochrane’s new editorial board process.
Patient, public, and/or healthcare consumer involvement:
Migraines affect over one billion people worldwide and is one of the most common neurological disorders. The review can be of widespread interest for those affected (children, young people, and adults) who suffer from migraine, also evaluating the effectiveness and safety of high-cost pharmaceutical drugs not always available all over the world.
The Cochrane International Mobility programme provides networking opportunities for people to learn from Cochrane colleagues in different parts of the world. The structure connects people and locations, facilitating exchange that enhances international collaboration and sharing best practice within Cochrane. The programme is open to anyone interested in contributing to Cochrane’s work. Cochrane Centres in Sweden, Austria, Italy, and The Netherlands began this initiative with several successful student exchanges. Online courses replaced in-person internships during Covid. The Neurological Sciences Field, following their past experience with in-person training courses in different European countries, including two residential ‘Summer Schools’ held in Umbria, Italy (2018-2019), decided to offer a one-year online course in 2020. An opportunity, given Covid restrictions, to continue training Cochrane methodology.
Objectives:
Training new Cochrane review authors, knowledgeable in Cochrane methodology, with the aim of working together to produce a Cochrane systematic review.
Methods:
The online course was published through Cochrane TaskExchange; applications from neurologists and trainees living and working in different parts of the world were received. Six professionals were accepted, two in the US, two in Italy, one in Syria, one in Colombia. The course began in November 2020 and ended in December 2021 (Image 1). Five online lessons (Fig. 1) and five workshops with expert lecturers were organized (Fig. 2). Exercises were carried out in small groups between each lesson or workshop.
Outcomes:
Publication and successive citations of the review will represent outcome measures.
Conclusions:
Choosing a topic relevant to end-users and working together with course experts and the PaPaS CRG was an enthusiastic experience for new Cochrane authors. The review title proposed is ‘Prophylactic treatment with monoclonal antibodies targeting the CGRP pathway for migraine prevention.’
The protocol has been submitted following Cochrane’s new editorial board process.
Patient, public, and/or healthcare consumer involvement:
Migraines affect over one billion people worldwide and is one of the most common neurological disorders. The review can be of widespread interest for those affected (children, young people, and adults) who suffer from migraine, also evaluating the effectiveness and safety of high-cost pharmaceutical drugs not always available all over the world.